Human Development and the Life Course
Foundations of Health Science — HSCI 130
Kiffer G. Card, PhD, Faculty of Health Sciences, Simon Fraser University
Learning objectives for this lesson:
- Articulate the life-course perspective and distinguish cumulative, sensitive-period, and trajectory models
- Describe the Barker hypothesis and the Developmental Origins of Health and Disease (DOHaD) framework
- Recount the Dutch Hunger Winter cohort study
- Explain the ACE Study and its consequences for public health
- Identify the Canadian Longitudinal Study on Aging and the contemporary aging-research frontier
- Discuss healthy aging frameworks (Rowe & Kahn, WHO)
- Critically evaluate the Blue Zones claims
- Recognize life-course thinking as a precondition for understanding chronic disease prevention
HSCI 130 — Foundations of Health Science. Developed by Kiffer G. Card, PhD.
Glossary & Key Figures — Lesson 6
Module 6 · HSCI 130 · Foundations of Health Science
This page collects the key figures and concepts from this lesson. Use it as a study reference; HSCI 230, 341, and 410 will assume familiarity with this material.
Key figures introduced in this lesson
A consolidated course glossary will be published on the HSCI 130 index page.
Health Across the Life Course
Module 6 · HSCI 130 · Foundations of Health Science
Introduction and Overview
Life-course epidemiology rejects the idea that health is a snapshot of present circumstances. Instead, it treats current health as the cumulative result of exposures, opportunities, and choices stretching back to (and before) birth. The shift, which took root in epidemiological practice during the 1980s and 1990s, dramatically broadened the targets of public health intervention. Prenatal care, early childhood education, school health, and adolescent mental health became cardiovascular and cancer prevention by another name. The shift also produced methodological challenges that the field is still working through. This section introduces the basic conceptual frame.
Learning Objectives
- Distinguish cumulative, sensitive-period, and trajectory models of life-course epidemiology
- Articulate why the life-course frame broadened public health intervention targets
- Identify the founding British and Canadian birth cohorts
- Recognize the methodological challenges of life-course research (long follow-up, mortality selection, recall bias)
- Apply life-course thinking to a contemporary chronic disease example
Three life-course models
The critical-period model holds that exposures during specific developmental windows (in utero, infancy, puberty) have lasting effects that cannot be reversed later. Example: maternal folate deficiency during weeks 4-6 of pregnancy causes neural tube defects; supplementation afterward cannot undo it. The biological clock of development matters.
The accumulation (or 'risk-chain') model holds that exposures across the life course add up, with each adding incremental damage. Example: cumulative tobacco smoke exposure across decades predicts lung cancer risk far better than any single year. Time and dose matter together.
The pathway model holds that earlier exposures shape later ones through a chain. Example: childhood poverty → reduced school completion → lower-wage adult work → chronic stress → cardiovascular disease. The earlier exposure does not act directly; it sets the trajectory.
Life-course epidemiology incorporates several conceptual frameworks, not always carefully distinguished in the literature but conceptually important. The cumulative model views risk as additive over time: each exposure adds to a total risk burden, with effects roughly proportional to total exposure. Cumulative models fit conditions like cardiovascular disease and many cancers, where lifetime exposure to a risk factor (smoking pack-years, lifetime cholesterol-years) predicts outcome better than any single point-in-time measurement.
The sensitive-period model argues that certain developmental windows are uniquely consequential: what happens in utero, in early childhood, or in adolescence matters more than equivalent exposures at other times. The Barker hypothesis (discussed in the next section) is the canonical sensitive-period model. The ACE study (Section 3) is another. Sensitive-period models fit conditions where developmental programming has long-term consequences.
The trajectory model emphasizes that lives unfold along paths that are launched early and reinforced over time. Early-life socioeconomic disadvantage predicts educational attainment, which predicts adult occupation, which predicts adult income, which predicts adult health. Trajectory models fit conditions where the same exposure (early disadvantage) operates through multiple cumulative mechanisms over decades.
The three frameworks are not mutually exclusive. Most life-course research uses combinations: a sensitive period launches a trajectory whose cumulative consequences manifest as chronic disease in adulthood. The intellectual move that life-course epidemiology brings — relative to snapshot epidemiology — is the willingness to treat time as a variable, not as a fixed background (Kuh, Ben-Shlomo, Lynch, Hallqvist, & Power, 2003).
British birth cohorts: the founding longitudinal studies
The most important early life-course studies came from the UK. The 1946 birth cohort (officially the National Survey of Health and Development), launched by James Douglas and continued by Michael Wadsworth and Diana Kuh, recruited 5,362 babies born in one week of March 1946. It has been followed continuously ever since, with major data collections at most life stages (Wadsworth, Kuh, Richards, & Hardy, 2006). The 1958 cohort (NCDS) recruited approximately 17,000 babies born in one week of March 1958. The 1970 cohort (BCS70) recruited approximately 17,000 from a week in April 1970. The Millennium Cohort Study (MCS) recruited 19,000 babies born in 2000-2002. Together, these cohorts span seven decades and provide the closest thing public health has to a longitudinal record of how childhood circumstances translate into adult outcomes.
Findings from these cohorts have been foundational to life-course thinking. Childhood social class predicts adult mortality after controlling for adult social class. Birth weight predicts adult metabolic and cardiovascular outcomes. Childhood cognitive ability predicts adult mortality through pathways including occupational selection, health behaviors, and direct effects on diagnosis and management. Even handgrip strength in childhood predicts later-life function. The British birth cohorts have produced more than 6,000 peer-reviewed publications collectively and remain among the most productive longitudinal studies anywhere.
Canada's analogous studies are smaller but important. The National Longitudinal Survey of Children and Youth (NLSCY) ran from 1994 to 2010 and provided substantial life-course data on Canadian children. The CLSA (covered in Section 4) follows aging Canadians. Quebec's longitudinal studies, particularly the Quebec Longitudinal Study of Child Development, have been productive at the provincial level. The infrastructure for population-wide birth cohorts comparable to the British ones does not currently exist in Canada — a gap that the Canadian public health research community has been advocating to address.
Why life-course thinking changed everything
Pre-life-course epidemiology treated health risks as if they operated at the time of exposure. A 50-year-old with cardiovascular disease was assumed to have a problem with current diet, current smoking, current activity. Life-course epidemiology added: what happened to this person at age 5? Age 15? In their mother's pregnancy? The shift dramatically broadened the targets of public health intervention. Prenatal care, early childhood education, school health, and adolescent mental health became cardiovascular and cancer prevention by another name.
The intellectual move has political consequences. If chronic disease in adulthood is partly produced by childhood circumstances, then chronic disease prevention requires investment in childhood circumstances — including those of children who haven't yet had any chronic disease. The economic returns to early childhood investment, as documented by economist James Heckman (2006) and others in extensive research, are extraordinarily high: each dollar invested in high-quality early childhood programs produces ~$7-15 in returns over the life course, through health, education, employment, and reduced criminal justice involvement. The 'Heckman curve' is a standard reference in early childhood policy advocacy.
The implementation is harder than the science. Early childhood investment produces returns 40-60 years later. Most political systems can't sustain attention for that long. The visible programs that work — high-quality preschool, comprehensive prenatal care, evidence-based home visiting — require sustained funding through political cycles that don't naturally align with the timescales of the returns. The Nordic countries (particularly Sweden, Norway, and Denmark) have the most extensive early childhood investment infrastructure; their population health outcomes reflect this investment, with some lag.
What life-course thinking can't do
Life-course epidemiology has its limits. Long follow-up is expensive. Mortality selection is a problem (the people who survive to be measured at age 80 are systematically different from those who don't). Recall bias affects retrospective life-course measures (asking 70-year-olds about their childhood experiences). The methodological work required to translate life-course findings into causal claims is substantial — and the field has historically been somewhat permissive about causal language for what are often correlational findings.
The field also faces a particular interpretive challenge around individual responsibility. Findings that childhood adversity predicts adult disease can be misread as individual deterministic claims ('you are doomed because of what happened to you as a child'). The accurate reading is population-level (childhood adversity raises population-level risk) and probabilistic (most people with high ACE scores do not develop the predicted outcomes, and most people with serious chronic disease did not have particularly adverse childhoods). Communicating this nuance to non-technical audiences is hard. The ACE study, in particular, has been used in clinical and educational settings in ways that risk both individual fatalism and inappropriate diagnostic labeling.
Despite these limits, the life-course frame is now standard in chronic disease epidemiology. You will see it in HSCI 230 (as cohort study design), in HSCI 341 (as a particular framing of confounding and causal inference), and in HSCI 410 (as a methodological tradition for handling long-term exposure data). The frame is foundational; the implementation is incomplete.
Methods Spotlight
How we know — life-course study designs and cumulative-vs-sensitive-period analytics
Life-course epidemiology has developed methodological infrastructure to test what its conceptual framework requires. Birth cohort studies — recruiting all babies born in a defined period and following them for life — are the canonical design. The British birth cohorts (1946, 1958, 1970, 2000) span seven decades and provide the closest thing public health has to a longitudinal record of how childhood circumstances translate into adult outcomes. The Avon Longitudinal Study of Parents and Children (ALSPAC, 1991-) and the Canadian Healthy Infant Longitudinal Development (CHILD) Study (2008-) are contemporary equivalents at smaller scale.
The analytic methods that distinguish life-course epidemiology from snapshot epidemiology are formalized. Cumulative exposure models sum exposure across the life course and test whether total exposure (e.g., pack-years of smoking, lifetime occupational exposure) predicts outcomes better than current exposure alone. Sensitive-period models test whether exposure during specific developmental windows produces effects that exposure at other times does not. Trajectory models — implemented through group-based trajectory modeling (Nagin), latent class growth analysis, and growth mixture models — identify distinct trajectories of exposure or outcome across the life course rather than treating all participants as having similar paths. Cross-classification models simultaneously test multiple competing life-course hypotheses (cumulative, critical period, accumulation with chains of risk) within a single analytic framework.
The contemporary methodological frontier is data linkage. Pure prospective cohort studies are expensive and limited in size; linked administrative datasets (Statistics Canada's Social Data Linkage Environment, the UK Biobank's NHS linkage, Scandinavia's personal-identifier-based linkages across health, education, employment, and tax records) produce life-course datasets at sample sizes and follow-up durations that pure prospective designs cannot match. The methodological challenges are substantial: linkage error, selection effects in who gets linked, privacy and consent considerations, and the limitations of administrative data measurement. Canadian provincial repositories (Manitoba's MCHP, Ontario's ICES, BC's PopData) have produced foundational methods work in this area.
The challenge in interpreting life-course findings remains attribution. Many of the strongest life-course associations (childhood socioeconomic position predicting adult mortality, ACEs predicting adult disease) are robust across studies but the relative contributions of different mechanisms (biological programming, behavioral mediation, structural pathways, gene-environment interactions) are harder to disentangle. The contemporary work uses formal mediation analysis (Baron-Kenny approaches, modern causal mediation using counterfactual frameworks) to address these questions, though no single approach fully resolves them.
Why this matters today
The contemporary frontier of life-course epidemiology is data linkage. Administrative health data, education records, employment and tax records, and biomarker measurements can now be linked at scale to produce life-course datasets that previously required enormous prospective cohort investment. The Statistics Canada Social Data Linkage Environment, the UK's CALIBER and OpenSAFELY platforms, and analogous research-data infrastructures in Scandinavia are producing life-course evidence at sample sizes previously unimaginable. The methodological and ethical questions raised by these linkages are substantial; the substantive return is also substantial.
Reflection — Section 1
Pick a chronic disease you know something about and identify one early-life factor that predicts it. How would you intervene on that factor, and at what age?
Minimum 50 characters required. Save to reveal model answer.
Knowledge check — Section 1
Answer all five questions to check your understanding before moving on. Aim for at least 4 of 5 correct.
1. Life-course epidemiology treats current health as:
2. A 'sensitive period' in life-course epidemiology refers to:
3. The British 1946 birth cohort:
4. James Heckman's research on early childhood investment found:
5. A trajectory model in life-course epidemiology emphasizes:
DOHaD — Developmental Origins
Module 6 · HSCI 130 · Foundations of Health Science
Introduction and Overview
The strongest single set of findings in life-course epidemiology comes from the discovery that prenatal conditions program adult disease risk decades later. The framework is called Developmental Origins of Health and Disease (DOHaD), and its founding observation came from a British epidemiologist named David Barker who noticed an unusual pattern in geographic mortality data. The framework has been extended through animal studies, natural experiments (most famously the Dutch Hunger Winter cohort), and epigenetic mechanism research. It is now one of the most active areas of chronic disease research and has substantial public health policy implications.
Learning Objectives
- Recount David Barker's original observation and the Barker hypothesis
- Describe the Dutch Hunger Winter as a natural experiment
- Identify key findings from Dutch Hunger Winter follow-up research
- Articulate the 'thrifty phenotype' framing and its mechanistic implications
- Discuss the ethical complexity of communicating DOHaD findings to pregnant women
The Barker hypothesis
British epidemiologist David Barker observed in the 1980s that areas of England with high infant mortality in 1910 had high adult cardiovascular mortality in the 1970s — among survivors. He proposed that fetal undernutrition programmed the cardiovascular system for a thrifty phenotype that mismatched adult abundance. The 'developmental origins of health and disease' (DOHaD) field grew from this insight.
The 1944-45 Dutch famine, caused by a Nazi blockade, created a natural experiment: a well-fed population subjected to severe famine for a defined period. Children conceived during the famine had elevated rates of cardiovascular disease, diabetes, obesity, and schizophrenia decades later. The strongest evidence for prenatal nutritional programming in humans.
Subsequent work extended Barker's framework to gestational diabetes, maternal stress, environmental toxicants, and even paternal exposures. The field has shifted from 'undernutrition' to any disruption of the developmental environment.
DOHaD raises a genuine policy tension: emphasizing prenatal exposures can either motivate structural support for pregnant people, or shade into mother-blame when individual nutrition and behaviour are framed as the lever. Public health framings that emphasize maternal responsibility without funding maternal support are how a useful science can produce bad policy.
British epidemiologist David Barker (1938–2013) noticed in the 1980s an unusual geographic pattern in English mortality data. Areas of England with high infant mortality in the 1910s and 1920s — typically areas with substantial undernutrition in pregnant women — now had high adult cardiovascular mortality among the cohorts born in those years. The pattern was robust to controlling for adult socioeconomic conditions and adult risk factors. Barker hypothesized that fetal undernutrition produced permanent metabolic changes — what he called the 'thrifty phenotype' — that increased risk of cardiovascular and metabolic disease in adulthood. The hypothesis was published in The Lancet in 1986 (Barker & Osmond, 1986) and elaborated through a series of papers and books over the following decades (Barker, 1995).
The 'thrifty phenotype' idea is mechanistically intuitive. A fetus exposed to undernutrition adapts to scarce energy by developing a metabolic phenotype optimized for low caloric availability: smaller body size, lower metabolic rate, greater fat-storage efficiency, altered glucose-insulin dynamics. The adaptations are appropriate for the in utero environment and produce viable babies despite the constraints. But if the postnatal environment is one of caloric abundance — the mismatch between fetal programming and adult environment — then the same metabolic adaptations that supported in utero survival become risk factors for obesity, type 2 diabetes, and cardiovascular disease in adulthood.
The Barker hypothesis was initially controversial. The original Hertfordshire and Sheffield birth cohort data had methodological limitations. Several other groups failed to replicate aspects of the original findings. The mechanism — programming during a brief in utero exposure window producing decades-later disease — seemed implausible to many biologically-trained researchers. The hypothesis has been substantially confirmed by subsequent work: prospective cohorts, animal models, natural experiments (most famously the Dutch Hunger Winter), and increasingly clear epigenetic mechanism work. Barker died in 2013; the field he founded is now called DOHaD (Developmental Origins of Health and Disease) and has its own journal, professional society, and substantial research infrastructure.
The Dutch Hunger Winter cohort
Between November 1944 and May 1945, the Nazi occupation of the western Netherlands produced one of the most severe famines in modern European history. As retribution for Dutch resistance activities, the German military authority restricted food imports into the urban areas of the western provinces. Combined with an unusually cold winter and the disruption of agricultural production, the result was a famine in which daily caloric intake fell to approximately 400-800 kcal per day for several million people. The famine ended abruptly in May 1945 when Allied forces liberated the western Netherlands and food deliveries resumed.
The discrete, severe, and time-limited nature of the famine — combined with the excellent demographic and medical records the Dutch maintained throughout — made it a uniquely informative natural experiment for DOHaD research. The cohort of children exposed to famine in utero (and the comparison cohorts conceived just before or after the famine) has been studied prospectively since the 1970s. The accumulated findings constitute some of the strongest evidence for DOHaD in any human population.
The findings, developed by research groups led by Lambert Lumey, Aryeh Stein, Tessa Roseboom, and others over four decades (Lumey et al., 2007), are striking. Adults who were exposed to famine in the first trimester of pregnancy have elevated rates of cardiovascular disease, obesity, type 2 diabetes, schizophrenia, depression, and breast cancer. The effects vary by trimester of exposure: first-trimester exposure produces cardiovascular and metabolic effects; late-pregnancy exposure produces lower birth weight and (somewhat) different adult outcomes. Effects are detectable in the F2 generation (grandchildren of famine-exposed women), suggesting transgenerational effects through epigenetic mechanisms.
The Dutch Hunger Winter cohort is now among the most-cited evidence bases in DOHaD. The basic findings — that brief severe undernutrition in utero produces lifelong metabolic and cardiovascular risk — are robust and replicable. The mechanistic detail (which specific molecular changes mediate which adult outcomes) is the active frontier. Epigenetic mark studies in famine-exposed individuals have identified persistent DNA methylation differences at specific genes (IGF2 and others) that may mediate the metabolic effects (Heijmans et al., 2008). The Dutch Hunger Winter has shaped how the field understands not just fetal programming but transgenerational effects of environmental exposure.
DOHaD beyond the famine cohorts
The famine cohorts (Dutch, Chinese Great Leap Forward, Ukrainian Holodomor, Leningrad siege, others) provide the cleanest natural experiments but represent extreme exposures. The broader DOHaD evidence base extends to more common exposures. Maternal smoking during pregnancy is associated with elevated cardiovascular and metabolic disease risk in offspring. Maternal obesity and gestational diabetes produce metabolic effects in offspring. Maternal stress and depression during pregnancy are associated with offspring behavioral and mental health outcomes. Endocrine-disrupting chemical exposure during pregnancy (BPA, phthalates, PFAS) is linked to offspring outcomes including obesity, diabetes, and reproductive disorders.
Importantly, DOHaD effects are not limited to undernutrition. Maternal overnutrition and obesity during pregnancy appear to produce some of the same metabolic effects in offspring as undernutrition — the 'thrifty phenotype' framing extends to a broader 'mismatched programming' framework. Maternal exposure to various stressors during pregnancy (psychosocial stress, depression, intimate partner violence) is associated with offspring cortisol regulation, immune function, and neurodevelopment. The DOHaD framework has therefore expanded into a broader 'fetal programming' framework that includes nutritional, metabolic, endocrine, and psychosocial exposures.
The contemporary policy implications are substantial. Prenatal care has long been part of public health, but the DOHaD framework provides additional justification for prenatal interventions that extend beyond the immediate health of mother and baby. Reducing maternal stress, addressing maternal mental health, ensuring nutritional adequacy in pregnancy, and reducing prenatal environmental exposures are framed not just as immediate maternal-child health interventions but as long-term chronic disease prevention. The Health Canada-led federal Prenatal Nutrition Program and analogous provincial programs draw partly on DOHaD evidence.
The ethical complexity of DOHaD
DOHaD findings can be communicated in ways that produce useful policy attention or in ways that produce harmful individual blame. The same evidence that justifies collective action (improving maternal nutritional security, addressing food deserts, reducing chronic stress, providing accessible prenatal care, addressing intimate partner violence) does not automatically justify individual surveillance and judgment of pregnant women's behavior.
The literature on pregnant women's experiences of being monitored, judged, and lectured about behavior during pregnancy is substantial and not flattering to the field. Women have reported being shamed about weight gain, alcohol consumption, caffeine intake, exercise patterns, sleep position, dietary choices, and emotional state — sometimes by clinicians citing DOHaD-style evidence. The shaming has been particularly directed at women who are already marginalized: poor women, racialized women, immigrant women, Indigenous women. The intervention often produces compliance theater rather than behavior change, and produces stress that may itself have adverse effects.
Responsible communication of DOHaD treats it as a case for upstream collective policy — paid maternity leave, maternal mental health services, prenatal nutrition support, food security, structural reduction of stressors — not for individual surveillance and blame. The distinction between population science and individual prescription matters here as much as anywhere in public health. The findings establish that prenatal environments affect adult outcomes; they do not establish that any specific woman's choices in pregnancy determined her child's adult disease. The translation from population evidence to individual practice has to be done carefully.
Methods Spotlight
How we know — natural experiments, epigenetic biomarkers, and the DOHaD methodology
The DOHaD framework has been built on a methodologically distinctive evidence base. The strongest evidence comes from natural experiments: discrete severe exposures that affected identifiable cohorts in well-characterized ways. The Dutch Hunger Winter is the canonical example, but several other famine cohorts have produced parallel findings: the Chinese Great Leap Forward famine (1959-1961, with cohorts conceived during the famine producing elevated rates of cardiometabolic disease in adulthood), the Leningrad siege (1941-1944, with smaller and more methodologically contested findings), and the Ukrainian Holodomor (1932-1933, with emerging research). Each famine has produced findings consistent with the DOHaD framework while differing in details that reflect the specific exposure characteristics and follow-up infrastructure.
The animal model evidence base for DOHaD is equally substantial. Maternal undernutrition in rats and mice (Bertram et al., Petry et al., and many others) produces offspring with adult cardiometabolic phenotypes recognizable from the human findings. The animal models allow mechanistic dissection that human studies cannot — specifically identifying the molecular pathways through which prenatal exposure produces lasting metabolic changes. Cross-fostering experiments (transferring pups between mothers immediately after birth) distinguish prenatal from postnatal effects. Embryo transfer experiments distinguish maternal-environment from genetic effects. The conjunction of human natural-experiment evidence and animal mechanistic evidence is what gives DOHaD its methodological strength.
The epigenetic biomarker methodology has matured in the past 15 years. DNA methylation arrays (the Illumina 450K and EPIC platforms, measuring methylation at ~450K and ~850K sites respectively) provide genome-wide methylation profiles. The Horvath clock (2013) and subsequent biological age estimators (GrimAge, PhenoAge, DunedinPACE) use methylation profiles to estimate biological age, often exceeding chronological age in people with adverse early-life exposures. The Dutch Hunger Winter cohort has been studied epigenetically, with consistent findings of persistent methylation differences at specific genes (IGF2 and others) in famine-exposed individuals six decades after exposure.
The contemporary methodological challenges include distinguishing causation from confounding in epigenetic associations (most are correlational), tissue-specific methylation patterns (most studies use blood, but tissue-of-interest may show different patterns), and the challenge of moving from methylation differences to phenotype prediction. Mendelian randomization approaches using genetic variants associated with methylation patterns are emerging as a partial solution. The field is moving fast enough that methodological best practice in 2026 may not be best practice in 2030.
Why this matters today
Contemporary DOHaD research is increasingly focused on epigenetic mechanisms — the molecular biology by which environmental exposure during sensitive periods produces persistent regulatory changes in gene expression. The 2020s have seen substantial progress in characterizing DNA methylation, histone modification, and non-coding RNA changes associated with various prenatal exposures. Whether these mechanisms can be specifically targeted (epigenetic therapy in childhood to reverse adverse prenatal programming) is one of the major open questions of the field. The policy translation is also evolving: several jurisdictions have introduced DOHaD-informed prenatal nutrition programs, and the case for paid parental leave has been increasingly framed in DOHaD terms.
Reflection — Section 2
DOHaD findings are sometimes used to justify intensive monitoring of pregnant women's behaviour. How would you balance the legitimate science with the risk of blaming mothers for adult disease?
Minimum 50 characters required. Save to reveal model answer.
Knowledge check — Section 2
Answer all five questions to check your understanding before moving on. Aim for at least 4 of 5 correct.
1. The Barker hypothesis proposes that:
2. The Dutch Hunger Winter cohort is informative because:
3. First-trimester famine exposure in the Dutch Hunger Winter cohort is associated with elevated adult rates of:
4. The 'thrifty phenotype' refers to:
5. DOHaD findings most defensibly justify:
ACEs — Childhood Adversity
Module 6 · HSCI 130 · Foundations of Health Science
Introduction and Overview
If DOHaD established that prenatal environment matters, the ACE Study established that early-childhood adversity matters across an extraordinarily wide range of adult outcomes. The ACE framework — and the population health response it produced — has been one of the most influential developments in public health of the past quarter-century. It has also been substantially critiqued in ways that any user should know. This section walks through the founding study, the replications and extensions, the contemporary applications, and the limits of the framework.
Learning Objectives
- Recount the Felitti-Anda ACE Study (1998) and its core findings
- Identify the ten original ACE categories
- Explain the dose-response relationship between ACE count and adult health outcomes
- Articulate the public health applications of ACE research
- Discuss the critiques of ACE research and how they have refined the framework
The Felitti-Anda study
The ACE Study originated from an unexpected source: an obesity-treatment program at Kaiser Permanente in San Diego in the late 1980s. Vincent Felitti, a physician running the program, observed that patients who lost substantial weight often subsequently dropped out of the program before reaching their goals. Routine interviews suggested that for many patients, weight gain was a coping response to early-life trauma, particularly childhood sexual abuse. Felitti partnered with Robert Anda at the U.S. CDC to design a systematic investigation.
Felitti and Anda administered a 10-item questionnaire about childhood adversity to over 17,000 adult Kaiser members between 1995 and 1997. The questionnaire covered three categories of adversity: abuse (psychological, physical, sexual), neglect (physical, emotional), and household dysfunction (substance abuse in the household, mental illness in the household, parental separation/divorce, domestic violence against the mother, household criminal activity). Each yes-or-no item added 1 to a participant's ACE score (range 0-10).
The findings, published in the American Journal of Preventive Medicine in 1998 (Felitti et al., 1998), were striking. There was a strong, dose-response relationship between ACE count and a wide range of adult outcomes. Adults with ACE scores of 4 or more had approximately 4× the odds of severe depression, 7× the odds of alcoholism, 12× the odds of attempted suicide, 2-4× the odds of smoking, and elevated risk for COPD, ischemic heart disease, cancer, diabetes, and other conditions. The relationship was monotonic — more ACEs predicted worse outcomes — and the dose-response was steep.
The original ACE study has been replicated hundreds of times across different populations, different ACE-measurement instruments, and different outcome measures. The basic findings hold. The dose-response relationship between childhood adversity and adult health is one of the most robust observations in social epidemiology.
Mechanisms: from adversity to adult disease
How does childhood adversity produce adult disease? The mechanism research has identified several pathways, often operating simultaneously. Biological pathways: chronic activation of stress response systems (HPA axis, sympathetic nervous system, inflammatory cytokines) during sensitive developmental periods produces lasting alterations in immune function, cardiovascular regulation, and metabolic health. Behavioral pathways: people with high ACE exposure are more likely to engage in health-risk behaviors (smoking, substance use, risky sex) that are often coping responses to ongoing distress and that produce direct adult health consequences. Social pathways: childhood adversity disrupts educational trajectories, occupational opportunities, and relationship stability, producing adult social positions associated with poorer health. Epigenetic pathways: persistent changes in gene expression patterns following childhood adversity have been characterized in cortisol-regulation genes, immune genes, and others (Hertzman & Boyce, 2010).
The relative contributions of these pathways vary by outcome. Cardiovascular effects appear to operate substantially through inflammatory and HPA-axis mechanisms, with behavioral mediators contributing. Mental health effects involve all four pathways. Some effects (e.g., chronic pain conditions, fibromyalgia, irritable bowel syndrome) appear to involve pathways that traditional epidemiology has been slow to characterize. The biological mechanism work is ongoing and is increasingly central to how the field communicates ACE research — the implication being that childhood adversity gets 'under the skin' through specific physiological pathways, not just through behavioral choices.
Critiques and refinements
The ACE framework has been heavily used and heavily critiqued, often by people whose work overlaps substantially. Several critiques are worth knowing.
The ACE score is a blunt instrument. It treats radically different experiences as equivalent (a parental divorce counts the same as repeated sexual abuse). It doesn't distinguish severity, chronicity, age of onset, or relational context. The 10 items omit categories of adversity (poverty, racism, community violence, housing instability) that are likely as important as the listed items. Several alternative ACE measures have been developed (Philadelphia ACEs Project's expanded items, the WHO ACE-International Questionnaire) that address these gaps, but the original 10-item score remains the most-used because of its simplicity and comparability across studies.
Population vs. individual. ACE findings are population-level. An adult with an ACE score of 6 has elevated population-level risk for many conditions. But most adults with high ACE scores do not develop the predicted conditions, and most adults with serious chronic conditions did not have particularly high ACE scores. Treating an ACE score as an individual diagnosis or prognosis is a category error. The clinical use of ACE screening — increasingly common in some healthcare systems — has been criticized for producing labeling effects and for shifting attention from structural factors to individual histories.
Adversity and resilience. The original ACE framework focused on adversity but not on protective factors. Subsequent work has emphasized that protective childhood experiences (stable adult relationships, community connection, predictable routines, sense of safety) buffer against the effects of adversity. Counting Positive Childhood Experiences (PCEs) alongside ACEs produces better prediction of adult outcomes than ACE counting alone (Bethell, Jones, Gombojav, Linkenbach, & Sege, 2019). The contemporary framing increasingly emphasizes the developmental ecology of childhood, not just the absence of harm.
Structural vs. individual framing. Many of the experiences captured by ACEs (household dysfunction, parental substance use, parental mental illness, parental incarceration) are themselves consequences of structural conditions (poverty, racism, criminalized substance use, inadequate mental health treatment). Addressing 'ACEs' without addressing these structural conditions risks treating downstream symptoms while ignoring upstream causes. The most effective public health responses to ACEs are usually structural ones (poverty reduction, evidence-based home visiting, paid family leave, addiction treatment as healthcare rather than as criminal justice).
The contemporary public health response
ACE research has driven substantial public health policy in the past 25 years. Trauma-informed care — the integration of awareness of trauma into clinical practice across primary care, mental health, education, and child welfare — has become standard in many jurisdictions. The state of California implemented universal ACE screening in pediatric Medi-Cal in 2020, the first US state to do so at scale. Several Canadian provinces have introduced trauma-informed practice frameworks across their health and social services systems.
The specific interventions with the strongest evidence are upstream — they aim to prevent ACEs rather than to mitigate their downstream effects. Evidence-based home visiting programs (Nurse-Family Partnership, Healthy Families America) reduce child maltreatment in randomized trials. Earned income tax credits and child benefits reduce child poverty in ways that improve childhood circumstances. Substance use treatment for parents reduces parental impairment as an ACE for children. Comprehensive paid parental leave reduces stressors during the early postnatal period. Each of these interventions has substantial evidence of effectiveness; collectively, they would substantially reduce ACE prevalence in the next generation if implemented at scale.
The downstream interventions — therapy and support for adults with high ACE histories — are also important but show smaller and less consistent effects. The general public health lesson is the same one we encounter throughout the course: upstream structural intervention produces larger and more durable effects than downstream individual intervention. ACE research strengthens the case for early childhood policy investment, with the empirical justification that the consequences of childhood adversity extend across the entire life course.
Methods Spotlight
How we know — ACE measurement, instrument critiques, and trauma-informed methodology
The original Felitti-Anda ACE study (1998) used a 10-item questionnaire that has become the dominant measure of childhood adversity in population health research. The questionnaire was originally developed for the Kaiser Health Appraisal Clinic and was administered to >17,000 Kaiser members. The items grouped into three categories: abuse (psychological, physical, sexual), neglect (physical, emotional), and household dysfunction (substance abuse, mental illness, parental separation, domestic violence, household criminal activity).
The instrument has been heavily critiqued, in ways important for any user. Item construction: each item is binary (yes/no), with no measurement of severity, chronicity, age of onset, or relational context. Score interpretation: the simple sum gives equal weight to qualitatively different experiences. Cultural specificity: the items reflect 1990s middle-class American assumptions about what constitutes adversity; some experiences relevant in other contexts (immigration trauma, racism, community violence, poverty itself) are not captured. Recall validity: adult report of childhood experiences is subject to recall bias and current-mental-state effects. Population homogeneity: the original Kaiser sample was substantially white, middle-class, and insured; generalization to other populations requires care.
Several alternative instruments address these critiques. The Philadelphia ACE Project expanded items to include witnessing violence, racism, bullying, and unsafe neighborhoods. The WHO ACE-International Questionnaire (ACE-IQ) developed a globally-applicable instrument. The Childhood Trauma Questionnaire (CTQ, Bernstein and Fink 1998) measures severity rather than presence/absence on 28 items, producing continuous subscale scores for each type of adversity. The Adverse Childhood Experiences International Questionnaire developed by Bethell et al. extends the framework with positive childhood experiences. None of these alternative instruments has fully displaced the original 10-item ACE score because the original's simplicity makes it tractable in large samples.
The contemporary methodological frontier includes biological mediator measurement (HPA-axis function, allostatic load, inflammatory markers, telomere length) that test specific pathways from adversity to outcome; positive childhood experiences (PCEs) measurement that captures protective factors alongside adversity; structural adversity measurement (neighborhood disadvantage, school quality, family income trajectories) using administrative and contextual data; and longitudinal designs that measure adversity prospectively rather than retrospectively. The ALSPAC and NSCH (US National Survey of Children's Health) contain prospective adversity measurements that have enabled methodological work the cross-sectional ACE data cannot support. The work continues to elaborate the methodological infrastructure for what is now one of the major frameworks of public health research.
Why this matters today
In 2026, ACE research has matured into a substantial subfield with ongoing methodological refinement and increasingly nuanced policy application. The pandemic-era increase in household stressors, family separation, and economic precarity is likely to produce a measurable increase in ACE exposure for the children who lived through 2020-2023, with health consequences that will manifest over the coming decades. Canadian provincial responses to early childhood investment have varied substantially, with Quebec's $7-a-day daycare program (since 1997) representing the most comprehensive intervention and the strongest evidence base for population-level effects. The relationship between ACE research and the broader Indigenous health agenda — recognizing that residential schools, the Sixties Scoop, and ongoing child welfare overrepresentation are mass-scale ACE production systems — is a particularly active area of contemporary work.
Reflection — Section 3
An adult with an ACE score of 6 walks into a primary care clinic. What does that score tell the clinician — and what does it not tell them?
Minimum 50 characters required. Save to reveal model answer.
Knowledge check — Section 3
Answer all five questions to check your understanding before moving on. Aim for at least 4 of 5 correct.
1. The original ACE Study (Felitti & Anda, 1998) administered a 10-item questionnaire about childhood adversity to:
2. The 10 original ACE categories include:
3. Adults with ACE scores of 4 or more have approximately:
4. A primary critique of the ACE framework is:
5. Positive Childhood Experiences (PCEs) research shows that:
Healthy Aging and CLSA
Module 6 · HSCI 130 · Foundations of Health Science
Introduction and Overview
If most of life-course epidemiology has focused on early life, the recent expansion of older-adult research is one of the field's most active frontiers — and Canada is a global leader in it through the Canadian Longitudinal Study on Aging. This section walks through the conceptual framework for healthy aging research, the specific research infrastructure provided by CLSA, the contested 'Blue Zones' framework, and the contemporary policy frontier on aging populations.
Learning Objectives
- Distinguish chronological aging from healthy aging
- Describe the Rowe-Kahn 'successful aging' framework and its critiques
- Articulate the WHO healthy aging framework
- Identify the Canadian Longitudinal Study on Aging and its contributions
- Critically evaluate the Blue Zones claims
- Discuss the policy implications of an aging Canadian population
From successful to healthy aging
Key insight - Successful vs healthy aging
'Successful aging' (Rowe & Kahn 1987) emphasized minimizing disease and disability; 'healthy aging' (WHO 2015) reframes it as maintaining the functional ability to do what you value. The shift matters: a person with arthritis who plays piano daily, walks slowly with friends, and lives independently is aging well by the WHO definition, even with measurable disease. Outcomes depend on which definition the system is optimizing for.
In 1987, John Rowe and Robert Kahn published a paper in Science distinguishing 'usual' from 'successful' aging (Rowe & Kahn, 1987). They argued that the public health and clinical research literature had conflated 'normal' aging (age-related declines) with 'usual' aging (the average trajectory, which includes substantial preventable decline) — and that some older adults achieved 'successful' aging that combined low risk of disease and disability, high cognitive and physical function, and active engagement in life. The framework launched the MacArthur Studies of Successful Aging, which followed approximately 1,000 'high-functioning' older adults for over a decade and produced substantial findings on what predicted continued function.
The Rowe-Kahn framework became the dominant aging-research framework for a generation. It generated useful research questions (what protects function? what risk factors are modifiable in old age? what determines successful aging?). It also faced substantial critique. The 'successful aging' construct was criticized as aspirational, ableist, and culturally narrow. It implied that aging with disability or chronic disease was 'unsuccessful,' which was both empirically and ethically problematic. The framework also tended to attribute successful aging to individual characteristics (behaviors, attitudes, choices) rather than structural conditions (income, social position, access to healthcare).
The WHO's contemporary healthy aging framework, articulated in the 2015 World Report on Ageing and Health, defines healthy aging as 'the process of developing and maintaining the functional ability that enables wellbeing in older age.' The framework emphasizes function rather than disease absence and is more inclusive of people aging with disability. It treats aging as a multidimensional process that interacts with environmental conditions to produce the actual capacities and experiences of older adults. The framework has been adopted by the WHO and is increasingly the reference framework for international aging policy. The 2021-2030 'Decade of Healthy Ageing' is the WHO's flagship aging initiative.
The Canadian Longitudinal Study on Aging (CLSA)
Launched in 2010 under the scientific leadership of Parminder Raina (McMaster), Christina Wolfson (McGill), Susan Kirkland (Dalhousie), and others (Raina et al., 2019), the Canadian Longitudinal Study on Aging is one of the largest and most comprehensive aging cohorts in the world. CLSA recruited 51,338 Canadians aged 45-85 between 2010 and 2015, with two recruitment strategies: a 'tracking' cohort of 21,241 participants assessed by telephone, and a 'comprehensive' cohort of 30,097 participants assessed in-person at 11 Data Collection Sites across Canada with physical measurements and biospecimens. Both cohorts are followed every three years.
The CLSA collects an extraordinary breadth of data: demographics, socioeconomic position, social participation, health behaviors, physical and mental health, healthcare use, cognitive function, biomarkers (from blood, urine, hair), and (with consent) linkage to administrative health data. The 'comprehensive' cohort also has detailed physical measurements (anthropometry, blood pressure, lung function, hand grip strength, bone density, balance, cognitive testing). The breadth means CLSA can address questions that no single specialized cohort could.
CLSA has produced more than 600 peer-reviewed publications as of 2026, addressing topics from sleep and cognition to social isolation, frailty, multimorbidity, retirement, and healthcare use. The cohort has provided substantial COVID-19-era evidence on aging populations, including studies of vaccine response, social isolation effects, and acceleration of cognitive decline. The CLSA Data and Sample Repository is available to qualified researchers through a controlled-access portal, and the dataset is one of Canada's most-used population health research resources.
The CLSA is not without limitations. Its sample is somewhat skewed toward higher-SES, higher-educated, urban Canadians, with smaller representation from Indigenous communities, rural and remote communities, and non-white populations. Recruitment of these populations has been a stated priority in subsequent waves but remains imperfect. The age range (45-85 at baseline) means the cohort doesn't capture the very-old population (90+) or younger adults. Despite these limits, CLSA is one of the most powerful longitudinal aging datasets globally and will continue to produce substantial evidence on Canadian aging through at least 2040.
The Blue Zones and the limits of inference
The 'Blue Zones' framing — the claim that five specific regions of the world (Sardinia, Italy; Okinawa, Japan; Nicoya Peninsula, Costa Rica; Ikaria, Greece; Loma Linda, California) have unusual concentrations of centenarians and exceptional longevity — has been popularized into a substantial commercial wellness brand by Dan Buettner and collaborators. The underlying research, originally published in academic literature and subsequently developed into popular books, has been criticized on multiple grounds that any public health student should know.
Selection effects. The five 'Blue Zones' were selected through a process that was not fully systematic. Other regions with similar demographic profiles were not consistently considered. The selection process appears to have favored regions where the popular narrative could be developed.
Centenarian counts. Subsequent analysis by demographer Saul Justin Newman (2019) has shown that several of the Blue Zone centenarian counts are likely artifacts of pension fraud, poor vital records, and identity confusion (the deceased's identity continuing to receive pension benefits, the wrong birthdate on records). When Newman applied stricter demographic verification, the centenarian density of several Blue Zones falls substantially. The Okinawan claim, in particular, depends on Japanese vital records that have substantial inconsistencies. Italian, Costa Rican, and Greek claims face similar verification challenges.
Over-attribution to lifestyle. Even granting some unusual longevity in these regions, the attribution to specific lifestyle factors (Mediterranean diet, social engagement, religious participation, daily moderate activity) is empirically weak. Many other regions with similar lifestyles do not show similar longevity. Many regions with very different lifestyles show comparable longevity. The Blue Zones narrative cherry-picks lifestyle features that fit popular wellness messaging and ignores features that don't.
The Blue Zones case is a useful cautionary example in popular health science. A real underlying observation (some regions have more old people than expected) can support either careful science or commercial wellness storytelling, and the public usually sees the second version. The case also illustrates how Western wellness narratives shape and distort the representation of non-Western traditional practices. The Okinawan diet, for instance, has been substantially repackaged as a wellness product in ways that don't match contemporary Okinawan dietary patterns and that obscure the substantial Westernization of Okinawan diet over the past three generations.
Aging populations as policy
Take your capstone topic. In the box below or in your notes, identify one significant exposure or risk factor that:
- Operates in the prenatal period (or before conception)
- Operates in childhood/adolescence
- Operates in adulthood
- Operates in older age
This is the basic move of life-course epidemiology: the same disease can have entry points across all four windows, and effective public health intervenes at multiple stages, not just the symptomatic one.
Canada, like most industrialized countries, has an aging population. The proportion of Canadians aged 65 and over has risen from approximately 8% in 1970 to approximately 19% in 2026 and is projected to reach approximately 25% by 2040. The age structure shift has substantial implications for healthcare demand, pension and retirement systems, labour markets, housing, and social services. Whether the implications are 'crises' (as the popular framing often suggests) or 'transitions' (as more careful analysis suggests) depends substantially on policy choices.
The Canadian policy landscape on aging includes several active fronts. Long-term care has been the subject of substantial attention since the COVID-19 pandemic exposed catastrophic failures in many provincial long-term care systems (over 80% of Canada's COVID-19 deaths in the first wave occurred in long-term care, the highest proportion of any OECD country). Reforms are slow and uneven. Home and community care has been expanding in some provinces but is unevenly available. Healthcare integration for older adults with multiple chronic conditions and complex care needs remains a substantial system challenge — most provincial healthcare systems are organized around acute-care specialties rather than integrated primary care for complex older adults. Social participation — addressing loneliness, social isolation, and meaningful engagement in later life — is an active research and policy priority but with limited specific intervention infrastructure.
The contemporary direction of healthy aging policy is increasingly toward 'age-friendly' communities and environments — the WHO Age-Friendly Cities framework, adopted by hundreds of municipalities globally including substantial Canadian participation, structures urban planning, transportation, housing, and social services around the needs of aging populations. The framework is consistent with the broader WHO healthy aging framework: focus on environmental and functional supports for aging, not just on individual behavior. The implementation is uneven and the evidence base for specific Age-Friendly interventions is still developing, but the direction is clearly toward structural and environmental aging support rather than primarily individual behavioral intervention.
Methods Spotlight
How we know — CLSA methodology, frailty indices, and the contemporary aging-research toolkit
Aging research has methodological infrastructure that has expanded substantially since the 1980s, with Canada now operating one of the most-developed national aging research platforms. The Canadian Longitudinal Study on Aging (CLSA) illustrates the modern multi-modal cohort approach: 51,338 participants aged 45-85 at baseline (2010-2015), follow-up every three years, with a 'tracking' subcohort assessed by telephone and a 'comprehensive' subcohort assessed in person at 11 data collection sites with physical measurements (anthropometry, blood pressure, lung function, hand grip strength, balance, bone density, cognitive testing) and biospecimens. The biospecimens enable downstream genetic, epigenetic, biomarker, and proteomic analyses. Linkage to administrative health data extends follow-up and enables outcome assessment without survey re-administration.
Several aging-specific measures dominate the methodological landscape. Frailty indices aggregate deficit accumulation across multiple domains (mobility, cognition, comorbidity, function) into a single score that predicts mortality and adverse outcomes better than chronological age alone. The Rockwood Frailty Index (Rockwood & Mitnitski, 2007) is the most-used; the Fried phenotype (Fried et al., 2001) is a competing instrument with five specific criteria. Allostatic load (McEwen & Stellar, 1993; McEwen, 1998) is a multi-system biomarker composite (cardiovascular, metabolic, inflammatory, neuroendocrine) intended to capture cumulative physiological dysregulation. Biological age estimators based on DNA methylation (Horvath clock, GrimAge), telomere length, or biomarker composites attempt to provide single-summary measures of physiological aging that decouple from chronological age.
The 'Blue Zones' framework has been criticized methodologically in ways students should know. Saul Newman's work (preprinted 2019, peer-reviewed 2024) examined the demographic basis of supercentenarian (110+) claims and found that many were artifacts of pension fraud, vital records errors, and identity confusion. When stricter demographic verification is applied, several Blue Zone regions show centenarian densities much closer to the global average. The Newman analysis is technical but reads accessibly; it is becoming standard teaching material in aging research methods courses.
The contemporary methodological frontier includes digital phenotyping using wearable devices and smartphone sensors to characterize aging trajectories in real time, biological age clocks increasingly used as primary outcomes in clinical trials, cellular senescence biomarkers and senolytic drug development, and integration of aging research with social determinants research. The CLSA's longitudinal follow-up through 2040 and beyond will support substantial methodological development in this area for decades to come.
Why this matters today
In 2026, healthy aging is one of the most active areas of Canadian public health research, with CLSA-based studies producing substantial evidence on cognitive decline, frailty, multimorbidity, social isolation, and the trajectories of aging in different Canadian populations. The post-pandemic long-term care reform agenda is partially advancing in several provinces, with substantial structural challenges remaining. Indigenous aging research is a particularly active subfield, with attention to the substantially earlier onset of frailty and multimorbidity in Indigenous populations compared with non-Indigenous Canadians of the same chronological age — a finding that maps the cumulative effects of structural inequities documented across the life course.
Reflection — Section 4
Is 'successful aging' a useful concept, or does it pathologize ordinary aging?
Minimum 50 characters required. Save to reveal model answer.
Knowledge check — Section 4
Answer all five questions to check your understanding before moving on. Aim for at least 4 of 5 correct.
1. The Rowe-Kahn 'successful aging' framework (1987) included:
2. The WHO healthy aging framework emphasizes:
3. The Canadian Longitudinal Study on Aging (CLSA) recruited approximately:
4. CLSA follows participants every:
5. The 'Blue Zones' framework has been criticized for:
Synthesis, Spotlight, Capstone & Quiz
Module 6 · HSCI 130 · Foundations of Health Science
Bringing It All Together
This lesson has walked you through the full arc of the topic across all four sections. As you complete this final assessment, draw on each section to consolidate what you have learned and to prepare for the lessons that build on it.
The list below distills the core ideas the rest of the course will keep coming back to. Read them as a checklist: if any feel unfamiliar, jump back into the relevant section before you take the assessment, since later lessons will assume each of them as common ground.
Key Takeaways from Lesson 6
- Articulate the life-course perspective and distinguish cumulative, sensitive-period, and trajectory models
- Describe the Barker hypothesis and the Developmental Origins of Health and Disease (DOHaD) framework
- Recount the Dutch Hunger Winter cohort study
- Explain the ACE Study and its consequences for public health
- Identify the Canadian Longitudinal Study on Aging and the contemporary aging-research frontier
- Discuss healthy aging frameworks (Rowe & Kahn, WHO)
- Critically evaluate the Blue Zones claims
- Recognize life-course thinking as a precondition for understanding chronic disease prevention
Data Spotlight
CLSA recruited 51,338 Canadians aged 45-85 between 2010 and 2015, with biological sampling and home-based physical measurements for the 30,097-participant 'comprehensive' cohort. Follow-up is every three years, with both telephone-based and in-person components. The data are accessible to qualified researchers through a controlled-access portal. CLSA's strength is breadth: a single dataset can address questions about diet, social participation, sleep, cognition, biomarkers, frailty, healthcare use, and economic status simultaneously, with linkage to administrative health data adding further power. As of 2026, CLSA has supported more than 600 peer-reviewed publications and is one of Canada's most-used population health data resources. CLSA's strategic plan extends through at least 2040, meaning a substantial fraction of contemporary Canadian aging evidence will trace back to this cohort for decades.
Sample size: 51,338 at baseline (21,241 tracking + 30,097 comprehensive)
Age range at baseline: 45-85
Follow-up frequency: Every 3 years
Data types: Survey, biospecimen, physical measurement, linked administrative data
Lead institution: McMaster University (Parminder Raina, Scientific Director)
Access: Open to qualified researchers via controlled portal
Forward Link
Cohort and life-course designs are formalized in HSCI 230. The Dutch Hunger Winter, the British birth cohorts, the Whitehall studies, and the ACE Study will reappear there as case examples of specific epidemiological designs. HSCI 410 will cover analytical methods (linear mixed models, marginal structural models, joint modeling of longitudinal exposures and time-to-event outcomes) used in life-course data analysis.
Final Reflection
Looking back across this lesson
What is the single most important idea you take from this lesson into the rest of HSCI 130? Why?
Minimum 100 characters required.
Comprehensive Knowledge Check
This 15-question assessment covers all four sections of Lesson 6. Aim for at least 12 of 15 correct. You may retry until you reach mastery.
Comprehensive Final Assessment — Lesson 6 (15 Questions)
1. Life-course epidemiology treats current health as:
2. David Barker's hypothesis proposed that:
3. The Dutch Hunger Winter cohort is informative because:
4. The ACE Study (Felitti & Anda, 1998) found:
5. What is a 'sensitive period' in life-course epidemiology?
6. The Canadian Longitudinal Study on Aging (CLSA) recruited approximately:
7. Rowe and Kahn's 'successful aging' framework included:
8. The 'Blue Zones' framework has been criticized for:
9. The British 1946 birth cohort:
10. James Heckman's research on early childhood investment found:
11. DOHaD evidence justifies which kind of intervention?
12. Adults with ACE scores of 4 or more have approximately:
13. The contemporary WHO healthy aging framework emphasizes:
14. CLSA follows participants every:
15. The Felitti-Anda ACE Study (1998) administered to: